San Francisco, California – In a recent announcement, McDermott Will & Emery revealed that James Ravitz and Paul Gadiock have joined the firm as partners in their healthcare practice group. Ravitz, who specializes in the life sciences and healthcare industries, will offer regulatory counsel, enforcement defense, and litigation and compliance guidance to the firm’s clients. Gadiock, based in San Francisco, will provide counsel to FDA-regulated companies throughout the product lifecycle, drawing on his experience as a former member of the senior leadership at the FDA’s Center for Devices and Radiological Health.
Ravitz and Gadiock have made the move from Wilson Sonsini, along with other lawyers specializing in FDA and healthcare matters, as well as lawyers from the HHS Office of Inspector General. Their addition to McDermott Will & Emery’s healthcare practice group will further strengthen the firm’s expertise in these areas.
The healthcare industry continues to face complex regulatory challenges, particularly in the areas of life sciences and FDA regulations. With the arrival of Ravitz and Gadiock, McDermott Will & Emery aims to provide comprehensive legal support and guidance to its clients operating in these industries.
Ravitz brings extensive experience in handling regulatory matters, enforcement defense, and litigation within the life sciences and healthcare sectors. His expertise will be valuable to McDermott Will & Emery’s clients as they navigate the complex landscape of government regulations and compliance requirements.
Gadiock’s background as a former senior leader at the FDA’s Center for Devices and Radiological Health equips him with a deep understanding of FDA regulations and the challenges faced by FDA-regulated companies. He will play a crucial role in assisting clients throughout the entire product lifecycle, from research and development to market approval and post-market compliance.
McDermott Will & Emery’s healthcare practice group has gained a solid reputation for its expertise in assisting clients with regulatory matters, enforcement defense, and litigation in the healthcare and life sciences industries. With the addition of Ravitz and Gadiock, the firm is well-positioned to continue providing outstanding legal counsel to its clients.
The healthcare practice group at McDermott Will & Emery acts as a trusted advisor to clients in navigating the complex landscape of healthcare regulations and compliance. Ravitz and Gadiock’s extensive experience and knowledge will further enhance the firm’s ability to serve clients effectively and provide comprehensive legal solutions tailored to the unique needs of the healthcare industry.
The move by Ravitz and Gadiock from Wilson Sonsini to McDermott Will & Emery reflects the attractiveness of the firm’s healthcare practice group and its commitment to delivering top-notch legal services in the healthcare and life sciences sectors. McDermott Will & Emery continues to grow its healthcare team, solidifying its position as a leading law firm in this specialized field.
Note: This article was independently written and does not source information from any news company.